Early Cancer Detection in Blood Vessels Using Mobile Nanosensors
Reza Mosayebi, Arman Ahmadzadeh, Wayan Wicke, Vahid Jamali, Robert, Schober, and Masoumeh Nasiri-Kenari

TL;DR
This paper explores the use of mobile nanosensors injected into blood vessels to detect early cancer biomarkers, deriving analytical models and decision rules, and demonstrating improved detection performance over fixed sensors.
Contribution
It introduces a novel mobile nanosensor-based approach for early cancer detection in blood vessels, including analytical modeling and simple detection algorithms.
Findings
Optimal detector outperforms sum detector in accuracy.
Both detectors significantly outperform fixed nanosensor schemes.
Analytical models match particle-based simulation results.
Abstract
In this paper, we propose using mobile nanosensors (MNSs) for early stage anomaly detection. For concreteness, we focus on the detection of cancer cells located in a particular region of a blood vessel. These cancer cells produce and emit special molecules, so-called biomarkers, which are symptomatic for the presence of anomaly, into the cardiovascular system. Detection of cancer biomarkers with conventional blood tests is difficult in the early stages of a cancer due to the very low concentration of the biomarkers in the samples taken. However, close to the cancer cells, the concentration of the cancer biomarkers is high. Hence, detection is possible if a sensor with the ability to detect these biomarkers is placed in the vicinity of the cancer cells. Therefore, in this paper, we study the use of MNSs that are injected at a suitable injection site and can move through the blood vessels…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
